BOSTON: Overjet has recently received FDA clearance for Caries Assist, a transformative, AI-powered dental caries detection and outlining software for chairside aid and patient communication.
Last year, Overjet received the first U.S. Food and Drug Administration (FDA) clearance for Dental Assist for periodontal disease and quantification.
With this recent clearance, Overjet is now the only FDA-cleared software globally that can quantify bone levels with periodontal disease and detect and outline tooth decay for accurate patient care and communication.
Since its inception in 2018, Overjet, the leader in dental AI solutions, has been on a quest to improve oral health by making it easier for clinicians to confidently diagnose, for patients to understand why treatment is needed, and for insurance claims to be paid out efficiently. They are building an ecosystem to improve trust between providers, payers, and patients and to make every part of the process easier.
By gaining strong traction from both providers and payers, accumulating millions of data points, and constantly innovating with world-class dental experts and engineers, Overjet provides best-in-class products to their customers.
